Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252064 | SCV000303503 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000252064 | SCV000518775 | benign | not specified | 2016-02-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001079231 | SCV000752209 | benign | Glycogen storage disease IXa1 | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001079231 | SCV002806601 | benign | Glycogen storage disease IXa1 | 2021-08-17 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000675940 | SCV004563947 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000675940 | SCV005274394 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000675940 | SCV000801669 | benign | not provided | 2017-09-27 | no assertion criteria provided | clinical testing |